Clinical Trials Browser

Phase 2 × anlotinib × 30 days × Clear all

NCT07470840 2026-03-17

SBRT Plus Anlotinib and Bimepolizumab in Locally Advanced or Metastatic Renal Cell Carcinoma

Phase 2 Not yet recruiting

Carcinoma, Renal Cell

NCT07193186 2026-02-27

Anlotinib and Benmelstobart in DTC

Phase 2 Not yet recruiting

Thyroid Neoplasms